Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 Fractional Laser and PDT for Vulvar Lichen Sclerosus
NCT05228483Unknown
- Sponsor
- Xijing Hospital
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of aminolevulinic acid 10% gel in vulvar lichen sclerosus (LS) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Global Subjective Score 75 rate. Status: unknown.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT05228483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05228483.